loadpatents
name:-0.030772924423218
name:-0.025603055953979
name:-0.0038008689880371
Scarpelli; Rita Patent Filings

Scarpelli; Rita

Patent Applications and Registrations

Patent applications and USPTO patent grants for Scarpelli; Rita.The latest application filed is for "piperzinyl methanone naaa inhibitors".

Company Profile
3.24.26
  • Scarpelli; Rita - Rome IT
  • Scarpelli; Rita - Roma IT
  • Scarpelli; Rita - Genoa IT
  • Scarpelli; Rita - Genova IT
  • Scarpelli; Rita - Pomezia N/A IT
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Piperazinyl methanone NAAA inhibitors
Grant 10,556,892 - Piomelli , et al. Feb
2020-02-11
Inhibitors of fatty acid amide hydrolase (FAAH) enzyme with improved oral bioavailability and their use as medicaments
Grant 10,435,355 - Piomelli , et al. O
2019-10-08
Piperzinyl Methanone Naaa Inhibitors
App 20190177313 - Piomelli; Daniele ;   et al.
2019-06-13
Substituted benzoxazolone derivatives as acid ceramidase inhibitors, and their use as medicaments
Grant 10,213,416 - Piomelli , et al. Feb
2019-02-26
Inhibitors Of Fatty Acid Amide Hydrolase (faah) Enzyme With Improved Oral Bioavailability And Their Use As Medicaments
App 20180194722 - PIOMELLI; Daniele ;   et al.
2018-07-12
Dual inhibitor compounds for use in the treatment of neurodegenerative disorders and alzheimer's disease
Grant 9,975,861 - Cavalli , et al. May 22, 2
2018-05-22
Diarylalkylamine REV-ERB antagonists and their use as medicaments
Grant 9,949,968 - Grimaldi , et al. April 24, 2
2018-04-24
Inhibitors of fatty acid amide hydrolase (FAAH) enzyme with improved oral bioavailability and their use as medicaments
Grant 9,822,068 - Piomelli , et al. November 21, 2
2017-11-21
Substituted Benzoxazolone Derivatives As Acid Ceramidase Inhibitors, And Their Use As Medicaments
App 20170182009 - PIOMELLI; Daniele ;   et al.
2017-06-29
Diarylalkylamine Rev-erb Antagonists And Their Use As Medicaments
App 20170136009 - Grimaldi; Benedetto ;   et al.
2017-05-18
Multitarget FAAH and COX inhibitors and therapeutical uses thereof
Grant 9,630,914 - De Vivo , et al. April 25, 2
2017-04-25
Dual Inhibitor Compounds for Use in the Treatment of Neurodegenerative Disorders and Alzheimer's Disease
App 20170096406 - Cavalli; Andrea ;   et al.
2017-04-06
Diarylalkylamine REV-ERB antagonists and their use as medicaments
Grant 9,611,245 - Grimaldi , et al. April 4, 2
2017-04-04
Inhibitors Of Fatty Acid Amide Hydrolase (faah) Enzyme With Improved Oral Bioavailability And Their Use As Medicaments
App 20170088510 - PIOMELLI; Daniele ;   et al.
2017-03-30
Acid ceramidase inhibitors and their use as medicaments
Grant 9,428,465 - Piomelli , et al. August 30, 2
2016-08-30
Diarylalkylamine Rev-erb Antagonists And Their Use As Medicaments
App 20160237057 - Grimaldi; Benedetto ;   et al.
2016-08-18
Multitarget Faah And Cox Inhibitors And Therapeutical Uses Thereof
App 20150203447 - De Vivo; Marco ;   et al.
2015-07-23
Acid Ceramidase Inhibitors And Their Use As Medicaments
App 20150111892 - Piomelli; Daniele ;   et al.
2015-04-23
Saturated bicyclic heterocyclic derivatives as SMO antagonists
Grant 8,470,823 - Branca , et al. June 25, 2
2013-06-25
Tricyclic derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP)
Grant 8,362,030 - Ingenito , et al. January 29, 2
2013-01-29
Quinolin-4-one and 4-oxodihydrocinnoline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP)
Grant 8,354,413 - Jones , et al. January 15, 2
2013-01-15
Amide substituted indazoles as poly(ADP-ribose)polymerase(PARP) inhibitors
Grant 8,071,623 - Jones , et al. December 6, 2
2011-12-06
Heterocycle substituted ketone derivatives as histone deacetylase (HDAC) inhibitors
Grant 8,026,265 - Jones , et al. September 27, 2
2011-09-27
Quinolin-4-one And 4-oxodihyrdocinnoline Derivatives As Inhibitors Of Poly(adp-ribose) Polymerase (parp)
App 20110207720 - Jones; Philip ;   et al.
2011-08-25
Amide Substituted Indazole And Benzotriazole Derivatives As Poly(adp-ribose)polymerase (parp) Inhibitors
App 20110201657 - Boueres; Julia ;   et al.
2011-08-18
Saturated Bicyclic Heterocyclic Derivatives As Smo Antagonists
App 20110183989 - Branca; Danila ;   et al.
2011-07-28
Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (HDAC) inhibitors
Grant 7,977,374 - Ferrigno , et al. July 12, 2
2011-07-12
Tricyclic Derivatives As Inhibitors Of Poly(adp-ribose) Polymerase (parp)
App 20110053911 - Ingenito; Raffaele ;   et al.
2011-03-03
N-substituted Hydroxypyrimidinone Carboxamide Inhibitors Of Hiv Integrase
App 20110034449 - Crescenzi; Benedetta ;   et al.
2011-02-10
Heterocycle derivatives as histone deacetylase (HDAC) inhibitors
Grant 7,863,294 - Attenni , et al. January 4, 2
2011-01-04
N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
Grant 7,820,660 - Crescenzi , et al. October 26, 2
2010-10-26
Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (HDAC) inhibitors
Grant 7,799,825 - Ferrigno , et al. September 21, 2
2010-09-21
Heterocycle Substituted Ketone Derivatives as Histone Deacetylase (HDAC) Inhibitors
App 20100234374 - Jones; Philip ;   et al.
2010-09-16
4-oxo-4,5-dihydropyrrolo[1,2-A)quinoxaline derivatives as inhibitors of poly(ADP-ribose) polymerase (PARP)
App 20100152180 - Jones; Philip ;   et al.
2010-06-17
Amide Substituted Indazole and Benzotriazole Derivatives as Poly(ADP-Ribose)Polymerase (PARP) Inhibitors
App 20090275619 - Boueres; Julia ;   et al.
2009-11-05
Thiophene and Thiazole Substituted trifluoroethanone Derivatives as Histone Deacetylase (Hdac) Inhibitors
App 20090156591 - Ferrigno; Federica ;   et al.
2009-06-18
Thiophene and Thiazole Substituted Trifluoroethanone Derivatives as Histone Deacetylase (HDAC) Inhibitors
App 20090076101 - Ferrigno; Federica ;   et al.
2009-03-19
Heterocycle Derivatives As Histone Deacetylase (Hdac) Inhibitors
App 20090048228 - Attenni; Barbara ;   et al.
2009-02-19
N-Substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
App 20080275004 - Crescenzi; Benedetta ;   et al.
2008-11-06
N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
Grant 7,435,734 - Crescenzi , et al. October 14, 2
2008-10-14
Amide Derivatives as Inhibitors of Histone Deacetylase
App 20080221157 - Chakravarty; Prasun K. ;   et al.
2008-09-11
Amide substituted indazoles as poly(ADP-ribose)polymerase(PARP) inhibitors
App 20080167345 - Jones; Philip ;   et al.
2008-07-10
N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
App 20070123524 - Crescenzi; Benedetta ;   et al.
2007-05-31
N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
Grant 7,217,713 - Crescenzi , et al. May 15, 2
2007-05-15
N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
Grant 7,169,780 - Crescenzi , et al. January 30, 2
2007-01-30
N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase
App 20060258860 - Crescenzi; Benedetta ;   et al.
2006-11-16
N-substituted hydroxypyrimidinone carboxamide inhibitors of hiv integrase
App 20050025774 - Crescenzi, Benedetta ;   et al.
2005-02-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed